Core Viewpoint - The company announced that a major shareholder, Zhou Xiaoyan, plans to reduce their stake in the company by up to 2.2142 million shares, representing 0.38% of the total share capital, due to personal funding needs [1] Summary by Relevant Sections - Shareholder Reduction Plan - Zhou Xiaoyan, a natural person shareholder holding more than 5% of the company's shares, intends to reduce their holdings through centralized bidding and/or block trading [1] - The reduction is planned to occur within three months after the announcement, starting 15 trading days from the disclosure date [1] - The selling price will be determined based on the market price at the time of the reduction, indicating uncertainty in the implementation of this plan [1]
九强生物:股东拟减持不超0.38%公司股份